L Massimo, A Fossati-Guglielmoni, E Fortuna. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Adenocarcinoma/drug therapyAge FactorsChildChild, PreschoolDaunorubicin/adverse effectsDaunorubicin/therapeutic useFemaleHemangiosarcoma/drug therapyHodgkin Disease/drug therapyHumansInfantLeukemia/drug therapyLeukemia, Lymphoid/drug therapyLeukemia, Myeloid, Acute/drug therapyLymphoma, Large B-Cell, Diffuse/drug therapyLymphoma, Non-Hodgkin/drug therapyMaleNeoplasm Recurrence, LocalNeoplasms/drug therapyNeuroblastoma/drug therapyPeritoneal Neoplasms/drug therapySarcoma, Ewing/drug therapyTeratoma/drug therapyTesticular Neoplasms/drug therapyWilms Tumor/drug therapy
Substances： See more » Daunorubicin
Year: 1968 PMID： 4300437
Source DB: PubMed Journal: Helv Paediatr Acta ISSN： 0018-022X